| --- | --- | --- | --- | |-------|-------|-------|-------| | | | | | | | | | | | | | | | Safe Harbor Statements Special Note Regarding Forward-Looking Statements This presentation contains forward-looking statements, including statements about our plans to develop and commercialize our product candidates, our planned clinical trials for serlopitant, the timing of the availability of data from our clinical trials, the timing of our planned regulatory filings, the timing of and our ability to obtain and main ...